CXCR3 and COVID-19: In post-COVID-19 patients, we observed co-upregulation of groups of related red module proteins such as the CXCR3 chemokines (CXCL9, CXCL10, and CXCL11), and interleukin-1A (IL1A) and its antagonist IL1RN (Figures S4A and S4B).